044 28440990 srpharma@gmail.com

Trima Accel (Apheresis System)

The Trima Accel system delivers:

  • The right blood products at the right time
    • Respond to fluctuations in demand
    • Target specific blood types
  • In-process leukoreduction for ready-to-transfuse products
    • Maximizes blood center efficiencies
  • Standard Operating Procedures and scheduling requirements, opportunity for simple training
    • Potential for increased staff utilization
    • May allow more time for donors
  • Better procedure run times for platelet collections when compared to competitors*

The Trima Accel system is:

  • Simple, easy to use and quick to setup
  • Backed by Terumo BCT’s comprehensive support services
  • Better for donors
    • 25-40% shorter procedure times than comparable apheresis devices*
    • Single-needle procedures for a more comfortable donation experience#

The Trima Accel Automated Blood Collection System includes the Trima Accel device, the tubing set and the Trima Accel software. The system uses a centrifuge to separate whole blood into its components — platelets, plasma and red blood cells (RBCs). The Trima Accel system then collects the components based on customer-configured priorities and the donor’s physiology and blood count.

To meet collection goals, blood center administrators configure desired product volumes, yields and combinations. In addition, the device can be aligned with the blood center’s cell counter to ensure final products meet specifications.

Operating simply and safely:

  • Touch screen graphical interface enables easy operation
  • Blood centers configure within the boundaries of the Safety Box for maximum volume collected, minimum platelet post count, post hematocrit and maximum procedure time
  • The system determines which components the donor can safely donate


Platelet collections:

  • Define multiple platelet products with customized yield, volume and/or Plateletsconcentration for each platelet product including single, double or triple products — depending on donor capability
  • Ensure highly consistent platelet yields with sophisticated prediction algorithms
  • Leukoreduce platelet products using the integrated Leukocyte Reduction System (LRS) chamber without the platelet loss typically seen with post-collection filtration
  • Built-in system monitoring alerts the operator when product can be labeled as leukoreduced


RBC collections:

  • Define up to three RBC products — with highly consistent RBC volumes configurable between 150 ml and 250 ml — to match specific patient needs
  • Collect concurrently with platelets and/or plasma, or collect two RBC products simultaneously


Plasma collections:

  • Utilize multiple unique options to define the desired plasma products
  • Specify up to six fixed volumes for collection of standardized plasma units or maximize the plasma yield within given procedure and donor-dependent limits
  • Built-in system monitoring alerts the operator when product can be labeled as leukoreduced